-
Most Popular
Search Results
240 results for abv
Best Stocks 2022: What’s Not to Like About AbbVie (ABBV) Stock?
ABBV stock has rightly earned its place among the Best Stocks for 2022. This Dividend King is outperforming the S&P 500.
ABBV Stock: The FDA Blow That Just Sent AbbVie Tumbling on Wednesday
Here’s the big FDA-related news today that’s sparking a sharp selloff of pharmaceutical giant AbbVie and ABBV stock.
5 Top Stock Trades for Wednesday: ATVI, SHOP, CHGG, ABT, ABBV
Activision Blizzard, Shopify, Chegg, Abbott Labs and AbbVie were our top stock trades for Wednesday. That said, here’s a look at the charts.
Best-in-Class Quant Score Makes AbbVie (ABBV) a Strong Buy
AbbVie Inc (NYSE:ABBV) ranks in the top 10% of its industry group, Biotechnology, and in the top decile of sector group, Health Care, with a…
What Are AbbVie Shareholders Getting for Their $21 Billion? (ABBV, PCYC, JNJ)
AbbVie (ABBV) beat Johnson & Johnson (JNJ) to the punch with the deal to acquire Pharmacyclics (PCYC), but was it worth the hefty price tag?
Why AbbVie Inc (ABBV) Stock Is Still a Long-Term Winner
The market has been hot and cold on biotechs, but AbbVie stock is a great long-term winner. Here’s what you need to know about ABBV.
ABBV Stock: Could AbbVie Inc’s Gamble on Stemcentrx Pay Off?
Stemcentrx’s acquisition does little to alleviate the risk of the potential decrease in sales once Humira loses patent protection.
AbbVie Earnings: 5 Things for ABBV Stock Investors to Know About Q1
AbbVie (ABBV) earnings for the biopharmaceutical company’s first quarter of 2020 have ABBV stock on the move Friday after beating estimates.
AbbVie Inc (ABBV) Stock Isn’t Done Charting New Highs Yet
Pharma is a fast moving sector and the doors close quickly. With AbbVie’s (ABBV) door open, sell ABBV stock puts now!
AbbVie Stock: 3 Pros and 3 Cons to Consider Before Investing in ABBV
AbbVie has significant challenges, but they’re also not unique ones. Sizing up the outlook leads to a slightly bullish stance on ABBV stock.
AbbVie Earnings: ABBV Stock Drops 2% Despite Q2 Beats
AbbVie earnings on Friday have ABBV stock slighty lower despite the company beating EPS and revenue estimates from Wall Street.
AbbVie News: 5 Things for ABBV Investors to Know About Q3
AbbVie (ABBV) news for Friday includes results from the biopharmaceutical company’s earnings report for the third quarter of 2020.
High-Level Measures for Earnings Momentum Keep AbbVie (ABBV) a Strong Buy
Currently, AbbVie Inc (NYSE:ABBV) has a Strong Buy using Louis Navellier’s methodology for investing and his Portfolio Grader stock evaluator. ABBV has recently seen its…
Humira Sales Help AbbVie Inc (ABBV) to a Q1 Earnings Beat
AbbVie Inc, a pharmaceuticals company, has released its earnings report for the first quarter of 2015 and it beat analysts’ estimates
This Pharmaceutical Company is Oversold and Starting to Recover
This morning, I am recommending a bullish trade on AbbVie, Inc. (NYSE:ABBV), the biopharmaceutical company.
Nasdaq May Be In For a Tumble
The Nasdaq is looking very tired and barely able to hold above its 20-day moving average.
AbbVie Is More Than Just a Portfolio of Drugs and Acquisitions
With AbbVie’s buyout of Allergan officially finalized, ABBV stock has moved significantly higher since then. However, ABBV is so much more than this headline event.
What Kind of Easter Egg Hunt Are You In?
Why a search for stocks with huge growth potential should start in the small cap stock world.
ABBV Stock Earnings: AbbVie Beats EPS, Beats Revenue for Q2 2024
ABBV stock results show that AbbVie beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
ABBV Stock Earnings: AbbVie Beats EPS, Beats Revenue for Q1 2024
ABBV stock results show that AbbVie beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
AbbVie Inc (ABBV) Stock STILL Has Much More Room to Run Higher
ABBV stock has a lot more long-term oomph when you consider its current pipeline. Here’s why investors shouldn’t overlook AbbVie.
AbbVie Inc Stock Up on Strong Earnings, Guidance Update
AbbVie (ABBV) stock was up on Thursday following the release of a positive earnings report for the first quarter of the year.
Why Vale SA (VALE), Lululemon Athletica Inc. (LULU) and AbbVie Inc. (ABBV) Are 3 of Today’s Worst Stocks
AbbVie (ABBV), Lululemon Athletica (LULU) and Vale SA (VALE) led the marketwide bearish charge on Monday.
Why Is AbbVie Stock Down Today?
AbbVie (ABBV) stock is slipping on Friday following the release of the biopharmaceutical company’s earnings report for Q1 2022.
9 – 10 of 240 results
